Pharvaris (PHVS) Capital Expenditures (2020 - 2026)

Pharvaris (PHVS) has 7 years of Capital Expenditures data on file, last reported at -$60992.3 in Q1 2026.

• Quarterly Capital Expenditures rose 63.99% year-over-year to -$60992.3 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$65829.1 (up 90.87% YoY) and the FY2025 annual result came in at -$185988.4, up 68.06% from the prior year.
• Capital Expenditures fell to -$60992.3 in Q1 2026, from -$1790.3 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $58.9 billion in Q3 2023 to a low of -$58.9 billion in Q2 2023.
• A 5-year average of -$1.1 million and a median of -$30535.2 in 2023 frame the typical range for Capital Expenditures.
• The widest YoY moves for Capital Expenditures: up 114742419.94% in 2023, down 236328759.87% in 2023.
• Tracing PHVS's Capital Expenditures over 5 years: stood at -$24117.6 in 2022, then declined by 26.61% to -$30535.2 in 2023, then sank by 463.14% to -$171955.2 in 2024, then soared by 98.96% to -$1790.3 in 2025, then tumbled by 3306.82% to -$60992.3 in 2026.
• The last three Capital Expenditures figures came in at -$60992.3 (Q1 2026), -$1790.3 (Q4 2025), and -$21877.7 (Q3 2025), per Business Quant data.